Background: Brugada syndrome is an inherited cardiac channelopathy characterized by an increased risk of malignant ventricular arrhythmias and sudden cardiac death. Although the disorder typically presents during adulthood, infantile manifestations are rare and often exhibit a more aggressive clinical course. Fever is a well-recognized trigger for unmasking the Brugada electrocardiographic phenotype and precipitating life-threatening arrhythmias, particularly in individuals harboring pathogenic SCN5A variants. Reports of homozygous SCN5A variants presenting during infancy remain exceptionally uncommon.
Case Presentation: We report an 11-month-old previously healthy male who presented with a three-day history of febrile respiratory illness followed by lethargy, cyanotic episodes, apnea, and cardiogenic shock. Electrocardiography demonstrated sustained monomorphic ventricular tachycardia at 240 beats/minute that was refractory to vagal maneuvers and adenosine but successfully terminated following synchronized cardioversion. During pediatric intensive care admission, he developed recurrent ventricular tachycardia and atrial flutter requiring repeated electrical cardioversion and continuous lidocaine and amiodarone infusions. Initial echocardiography demonstrated right ventricular dilatation and paradoxical septal motion, raising concern for arrhythmogenic cardiomyopathy; however, cardiac magnetic resonance imaging revealed structurally normal ventricles without myocardial fibrosis or evidence of myocarditis. Extensive metabolic investigations were unremarkable. Whole-exome sequencing subsequently identified a homozygous SCN5A variant, establishing the diagnosis of an inherited sodium channelopathy consistent with Brugada syndrome. Despite temporary stabilization and discharge on amiodarone and propranolol, the patient experienced recurrent malignant ventricular arrhythmias two months later, culminating in refractory cardiogenic shock, prolonged cardiopulmonary resuscitation, progressive multiorgan failure, and death despite maximal intensive care support.
Conclusion: This case illustrates an exceptionally severe infantile phenotype of SCN5A-associated Brugada syndrome characterized by fever-triggered onset, mixed atrial and ventricular tachyarrhythmias, recurrent electrical instability, and fatal progression despite aggressive antiarrhythmic therapy. The report highlights the importance of early recognition of inherited channelopathies in infants presenting with unexplained ventricular tachycardia, the diagnostic value of comprehensive genetic testing when structural heart disease is excluded, and the challenges of risk stratification and management in this rare pediatric population

